In This Article:
Boston Scientific (BSX) has agreed to acquire Bolt Medical for $443 million in order to expand the former's cardiovascular treatment portfolio. The biomedical device manufacturer
Market Domination hosts Julie Hyman and Josh Lipton report on the latest news as Boston Scientific shares get a bump higher on this headline.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
This post was written by Luke Carberry Mogan.